- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Alan Menter Discusses 2022 Psoriasis Guideline Updates
Alan Menter, MD, chairman of dermatology, Baylor University Medical Center, discussed some of the updated psoriasis guidelines at the 2022 American Academy of Dermatology Annual Meeting.
Alan Menter, MD, chairman of dermatology, Baylor University Medical Center, discussed some of the updated psoriasis guidelines at the 2022 American Academy of Dermatology Annual Meeting.
Transcript
What are some of the updated psoriasis guidelines and recommendations for 2022, in relation to cardiovascular comorbidities?
The old theory that coronary artery disease is just caused by cholesterol is no longer true; it's caused by inflammation. Inflammation in the coronary artery is very similar to the inflammation in psoriasis, so improving the skin, we do believe, will improve coronary artery disease.
I chaired—co-chaired, there was 2 of us who chaired—the guidelines that we published in 2019 and 2020 in JAAD [Joint American Academy of Dermatology], and we had 6 papers, all of which were about 70 pages long. One of the guidelines related to coronary artery disease. We are relatively up to date with the fact that coronary artery disease is now inflammation driven, very similar inflammation to psoriasis, and not just driven by cholesterol.
HIVconsvX Vaccine Shows Safety, Immune Response in People on ART
March 10th 2025This research on a T-cell–targeting vaccines in HIV has implications for future study design to incorporate consideration of age and years on antiretroviral therapy (ART) to evaluate the level of immune reconstitution.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Ruxolitinib Cream Shows Long-Term Safety in AD, Potential for PN Treatment
March 8th 2025Two posters presented at the 2025 American Academy of Dermatology Annual Meeting reaffirmed the impact of ruxolitinib cream (Opzelura; Incyte) in atopic dermatitis (AD), while late-breaking research highlighted its potential efficacy in prurigo nodularis (PN).
Read More
Use of AI Lets Health System Find Lung Cancer at Early Stages
March 8th 2025Artificial intelligence (AI) helps a Sarasota, Florida, health system catch lung nodules that appear on CT scans for patients treated for scores of conditions, allowing them to be referred for a possible lung cancer diagnosis.
Read More
